Clinical experience with the progestogen-only pill
- PMID: 2125544
- DOI: 10.1016/0010-7824(90)90077-9
Clinical experience with the progestogen-only pill
Abstract
Experience with the progestogen-only pill (POP) in a family planning clinic is presented. From the clinic records, 408 women were identified who had opted to use a POP. Of these, 50 women had used the POP during lactation and these were excluded from the analysis. The remaining 358 women used the POP for up to 150 months, giving a total of 18,125 women-months of use. Three pregnancies occurred, giving a Pearl Index of 0.2 per 100 women-years. Non-menstrual side effects were minor and were reported by 77 women. For the women who discontinued the POP, the main reason was menstrual irregularity (47.5%). However, despite the long-term use by most of the women, almost 40% maintained a mostly regular menstrual pattern. Our findings suggest that the POP provides a very acceptable method of oral contraception for many women and that it should be more actively promoted.
Similar articles
-
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.Br J Obstet Gynaecol. 1984 Dec;91(12):1254-60. doi: 10.1111/j.1471-0528.1984.tb04747.x. Br J Obstet Gynaecol. 1984. PMID: 6440589 Clinical Trial.
-
Experience with ethynodiol diacetate and mestranol as an oral contraceptive.J Obstet Gynaecol India. 1968 Apr;18(2):287-93. J Obstet Gynaecol India. 1968. PMID: 12331821
-
Control of fertility with oral medication.West J Surg Obstet Gynecol. 1964 Jul-Aug;72:222-9. West J Surg Obstet Gynecol. 1964. PMID: 12305556
-
Subdermal progestin implant contraception.Curr Opin Obstet Gynecol. 1991 Aug;3(4):470-6. Curr Opin Obstet Gynecol. 1991. PMID: 1908716 Review.
-
Menstrual impact of contraception.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1513-22. doi: 10.1016/s0002-9378(94)05013-1. Am J Obstet Gynecol. 1994. PMID: 8178900 Review.
Cited by
-
Randomized, Crossover and Single-Dose Bioquivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 μg) in Healthy Female Volunteers.Sci Pharm. 2012 Apr-Jun;80(2):419-31. doi: 10.3797/scipharm.1111-18. Epub 2012 Mar 1. Sci Pharm. 2012. PMID: 22896827 Free PMC article.
-
Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial.BMC Womens Health. 2019 May 28;19(1):70. doi: 10.1186/s12905-019-0766-6. BMC Womens Health. 2019. PMID: 31138184 Free PMC article. Clinical Trial.
-
Interest in Continued Use After Participation in a Study of Over-the-Counter Progestin-Only Pills in the United States.Womens Health Rep (New Rochelle). 2022 Nov 9;3(1):904-914. doi: 10.1089/whr.2022.0056. eCollection 2022. Womens Health Rep (New Rochelle). 2022. PMID: 36479366 Free PMC article.
-
Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates.Open Access J Contracept. 2016 Mar 31;7:43-52. doi: 10.2147/OAJC.S85565. eCollection 2016. Open Access J Contracept. 2016. PMID: 29386936 Free PMC article. Review.
-
New Contraception Update - Annovera, Phexxi, Slynd, and Twirla.Curr Obstet Gynecol Rep. 2022 Mar;11(1):21-27. doi: 10.1007/s13669-021-00321-4. Epub 2022 Jan 6. Curr Obstet Gynecol Rep. 2022. PMID: 35795653 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical